Edwards Lifesciences Corp

102.14

USD

+1.32

+1.31%

Nov 06, 15:59 UTC -5

Closed

After-Market

102.10

-0.04

-0.04%

Edwards Lifesciences Corp (EW) Earnings

EW Earnings Reports

Positive Surprise Ratio

EW beat 27 of 43 last estimates.

63%

Next Report

Date of Next Report

Feb 08, 2027

Estimate for Q4 26 (Revenue/ EPS)

$1.75B

$0.73

Implied change from Q3 26 (Revenue/ EPS)

+2.09%

-8.75%

Implied change from Q4 25 (Revenue/ EPS)

+11.58%

+28.07%

Edwards Lifesciences Corp earnings per share and revenue

On Nov 04, 2026, EW reported earnings of 0.80 USD per share (EPS) for Q3 26, beating the estimate of 0.75 USD, resulting in a 5.40% surprise. Revenue reached 1.72 billion, compared to an expected 1.73 billion, with a -0.63% difference. The market reacted with a +1.46% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of 0.73 USD, with revenue projected to reach 1.75 billion USD, implying an decrease of -8.75% EPS, and increase of 2.09% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

GLOBUS MEDICAL INC

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.22

Actual

$1.23

Surprise

+0.75%

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

TransMedics Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.29

Actual

$0.51

Surprise

+71.31%

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Treace Medical Concepts, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.67%

Inogen Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.56

Surprise

-285.41%

Envoy Medical, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.68

Actual

-$0.50

Surprise

+26.47%

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

FAQ

What were Edwards Lifesciences Corp's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Edwards Lifesciences Corp reported EPS of $0.80, beating estimates by 5.4%, and revenue of $1.72B, -0.63% below expectations.

How did the market react to Edwards Lifesciences Corp's Q3 2026 earnings?

The stock price moved up 1.46%, changed from $99.37 before the earnings release to $100.82 the day after.

When is Edwards Lifesciences Corp expected to report next?

The next earning report is scheduled for Feb 08, 2027.

What are the forecasts for Edwards Lifesciences Corp's next earnings report?

Based on -- analysts, Edwards Lifesciences Corp is expected to report EPS of $0.73 and revenue of $1.75B for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.